Hey genius - that was a comparison between UC-MSC, AT-MSC and BM-MSC's. Not iPSC's.
No surprise you try to back over the tumour 'risk,' which has been comprehensively dealt with many times on this wall.
By the way, a couple of interesting comments about BM-MSC's:
That doesn't sound good for commercialisation!
Oh boy! That explains why MSB can only target children with SR-aGvHD, as opposed to targeting the 5x larger market of adults!
Hey genius - that was a comparison between UC-MSC, AT-MSC and...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
16.5¢ |
Change
-0.005(2.94%) |
Mkt cap ! $37.28M | |||
| Open | High | Low | Value | Volume |
| 16.5¢ | 16.5¢ | 16.0¢ | $59.06K | 360.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 50000 | 16.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 17.0¢ | 88474 | 2 |
View Market Depth
| Last trade - 13.19pm 19/06/2025 (20 minute delay) ? |
| CYP (ASX) Chart |